These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Nephrotoxicity related to new therapeutic compounds. Szeto CC; Chow KM Ren Fail; 2005; 27(3):329-33. PubMed ID: 15957551 [TBL] [Abstract][Full Text] [Related]
8. Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity. Kuhad A; Pilkhwal S; Sharma S; Tirkey N; Chopra K J Agric Food Chem; 2007 Dec; 55(25):10150-5. PubMed ID: 18001039 [TBL] [Abstract][Full Text] [Related]
9. Stromal cells protect against acute tubular injury via an endocrine effect. Bi B; Schmitt R; Israilova M; Nishio H; Cantley LG J Am Soc Nephrol; 2007 Sep; 18(9):2486-96. PubMed ID: 17656474 [TBL] [Abstract][Full Text] [Related]
10. The developing kidney and environmental toxins. Solhaug MJ; Bolger PM; Jose PA Pediatrics; 2004 Apr; 113(4 Suppl):1084-91. PubMed ID: 15060203 [TBL] [Abstract][Full Text] [Related]
11. Validation of putative genomic biomarkers of nephrotoxicity in rats. Wang EJ; Snyder RD; Fielden MR; Smith RJ; Gu YZ Toxicology; 2008 Apr; 246(2-3):91-100. PubMed ID: 18289764 [TBL] [Abstract][Full Text] [Related]
12. [Renal function and pharmacotherapy in children]. Jovanović O Srp Arh Celok Lek; 1995 Jun; 123 Suppl 1():15-21. PubMed ID: 18193796 [TBL] [Abstract][Full Text] [Related]
13. Biopsy proven acute tubular necrosis associated with vancomycin in a child: case report and literature review. Wu CY; Wang JS; Chiou YH; Chen CY; Su YT Ren Fail; 2007; 29(8):1059-61. PubMed ID: 18067058 [TBL] [Abstract][Full Text] [Related]
14. Protective effect of COMP-angiopoietin-1 on cyclosporine-induced renal injury in mice. Lee S; Kim W; Kim DH; Moon SO; Jung YJ; Lee AS; Kang KP; Jang KY; Lee SY; Sung MJ; Koh GY; Park SK Nephrol Dial Transplant; 2008 Sep; 23(9):2784-94. PubMed ID: 18463324 [TBL] [Abstract][Full Text] [Related]
16. [Secondary nephropathies in occupational health practice. I. Secondary nephropathies due to occupational exposure]. Antonowicz-Juchniewicz J; Jodkowska A; Kwiecińiska D Med Pr; 2006; 57(4):389-400. PubMed ID: 17133921 [TBL] [Abstract][Full Text] [Related]
17. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Launay-Vacher V; Rey JB; Isnard-Bagnis C; Deray G; Daouphars M; Cancer Chemother Pharmacol; 2008 May; 61(6):903-9. PubMed ID: 18317762 [TBL] [Abstract][Full Text] [Related]
18. [Secondary nephropathies in occupational health practice. II. Kidney disorders induced by drug and contrast media]. Antonowicz-Juchniewicz J; Jodkowska A; Kwiecińska D Med Pr; 2006; 57(5):455-68. PubMed ID: 17340988 [TBL] [Abstract][Full Text] [Related]
19. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway. Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013 [TBL] [Abstract][Full Text] [Related]